Jun 08 2019
Narcolepsy Meeting Focuses on Symptoms, But Some Urge Attention to Underlying Cause
h in Blogs
Excessive daytime sleepiness, interrupted nighttime sleep and “brain fog” are key symptoms that new drugs developed for the treatment of narcolepsy should target, patients told FDA Sept. 24.
During a four-hour meeting held as part of the agency’s patient-focused drug development initiative, dozens of patients and caregivers talked about the daily struggle to cope with the symptoms of narcolepsy despite currently approved treatments.